B Astedt

No ORCID on file · 6 papers in corpus
observational 1998
Inflammation ·doi:10.1023/a:1022322814288

The concentrations of the specific activators (u-PA and t-PA) and the specific inhibitors (PAI-1 and PAI-2) of the fibrinolytic system were analyzed in the peritoneal fluid in women suffering from intra-abdominal adhesions, endometriosis or…

observational 1998
Fertility and sterility ·doi:10.1016/s0015-0282(98)00285-4

OBJECTIVE: To determine whether there is a difference in fibrinolytic compounds in endometriotic tissue, endometrium, peritoneal fluid (PF), and plasma from women with endometriosis and in endometrium and PF from healthy women. DESIGN: Pro…

nonrandomized-trial 1994
International journal of fertility and menopausal studies

OBJECTIVE: Steroid hormones, especially estrogens, are known to affect hemostatic risk factors for thromboembolism, cardiovascular disease, and stroke. We examined these risk factors during depression of the serum estradiol concentration by…

other 1984
Acta obstetricia et gynecologica Scandinavica. Supplement ·doi:10.3109/00016348409156976
other 1981
Cancer ·doi:10.1002/1097-0142(19810915)48:6<1484::aid-cncr2820480634>3.0.co;2-l

Urokinase-like plasminogen activator (ULPA) was determined with a radioimmunoassay in uterine aspirates from 67 patients prior to curettage. In women with normal endometrial histology the mean concentration of ULPA was 5.4 +/- 2.5 microgram…

other 1971
British medical journal ·doi:10.1136/bmj.4.5785.458

Fibrin degradation products (F.D.P.) were determined in the serum of 163 women in whom ovarian tumours had been suspected on palpation at gynaecological examination and who were afterwards examined by laparoscopy or subjected to laparotomy.…